BXCL501 demonstrates significant reduction in agitation across all mood states (depressed, hypomanic, manic) in patients with bipolar disorder

被引:0
|
作者
Preskorn, Sheldon [1 ]
Goldberg, Joseph [2 ]
Finman, Jeffrey [3 ]
De Vivo, Michael [4 ]
Yocca, Frank [4 ]
Risinger, Robert [4 ]
机构
[1] Kansas Univ, Sch Med, Lawrence, KS USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] Jupiter Point Pharma Consulting LLC, Groton, CT USA
[4] BioXcel Therapeut, New Haven, CT USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
S18
引用
收藏
页码:84 / 84
页数:1
相关论文
共 16 条
  • [1] Safety and patient acceptability of BXCL501 for treating acute agitation in patients with bipolar disorder
    Zeller, Scott
    Citrome, Leslie
    Goldberg, Joseph
    Finman, Jeffrey
    De Vivo, Michael
    Yocca, Frank
    Risinger, Robert
    BIPOLAR DISORDERS, 2021, 23 : 61 - 62
  • [2] Effect of BXCL501 up to 24 hours for treating a cute agitation in patients with bipolar disorder
    Preskorn, Sheldon
    Citrome, Leslie
    Zeller, Scott
    Finman, Jeffrey
    De Vivo, Michael
    Yocca, Frank
    Risinger, Robert
    BIPOLAR DISORDERS, 2021, 23 : 84 - 85
  • [3] Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder
    Martínez-Arán, A
    Vieta, E
    Reinares, M
    Colom, F
    Torrent, C
    Sánchez-Moreno, J
    Benabarre, A
    Goikolea, JM
    Comes, M
    Salamero, M
    AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (02): : 262 - 270
  • [4] LONGITUDINAL EFFICACY ANALYSIS OF THE SUBLINGUAL FILM FORMULATION OF DEXMEDETOMIDINE (BXCL501) FOR THE TREATMENT OF ACUTE AGITATION ASSOCIATED WITH SCHIZOPHRENIAAND BIPOLAR DISORDER
    Jonsson, F.
    Lagraauw, H.
    Lathia, C.
    Adedoyin, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S56 - S56
  • [5] The associations between subjective and objective cognitive functioning across manic or hypomanic, depressed, and euthymic states in Chinese bipolar patients
    Lin, Xiaoling
    Lu, Dali
    Huang, Zhixin
    Chen, Wen
    Luo, Xia
    Zhu, Yinghua
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 249 : 73 - 81
  • [6] Impaired sensory processing measured by functional MRI in Bipolar disorder manic and depressed mood states
    Joseph J. Shaffer
    Casey P. Johnson
    Jess G. Fiedorowicz
    Gary E. Christensen
    John A. Wemmie
    Vincent A. Magnotta
    Brain Imaging and Behavior, 2018, 12 : 837 - 847
  • [7] Impaired sensory processing measured by functional MRI in Bipolar disorder manic and depressed mood states
    Shaffer, Joseph J., Jr.
    Johnson, Casey P.
    Fiedorowicz, Jess G.
    Christensen, Gary E.
    Wemmie, John A.
    Magnotta, Vincent A.
    BRAIN IMAGING AND BEHAVIOR, 2018, 12 (03) : 837 - 847
  • [8] Metabolic markers in patients with bipolar disorder across mood states
    Lee, S.
    Ha, T.
    Park, Y.
    Chung, T.
    Kim, E.
    Kim, J.
    Lee, H.
    Ha, K.
    BIPOLAR DISORDERS, 2015, 17 : 60 - 60
  • [9] Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients
    Munkholm, Klaus
    Weikop, Pia
    Kessing, Lars Vedel
    Vinberg, Maj
    BRAIN BEHAVIOR AND IMMUNITY, 2015, 43 : 205 - 213
  • [10] Inflammatory parameters and blood lipid values across the different mood states in patients with bipolar disorder
    Ekinci, Okan
    Ekinci, Ash Erkan
    KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY, 2020, 23 (04): : 414 - 422